What are you looking for?

Common searches: Departments, Hospitalisation, Professionals, Outpatient clinics, Health advice, Accreditations, Diseases, Diagnostic tests, Treatments, The birth of a child, Emergency, Visiting patients,

Activities

Curso Prematuridad: debate, casos prácticos y demostración a directo

 Más información: https://aula.vallhebron.com/aula/?go=info_cursos&curso=447&idioma=es

Professionals

Manuel Comabella López

 Dr. Manuel Comabella earned his medical degree at the University of Barcelona, completed his neurology residency at the Neurology Department of the Hospital Universitari Vall d’Hebron (HUVH), and earned his PhD at the Universitat Autònoma de Barcelona. Since 2004, Dr. Manuel Comabella is the Head of

Professionals

Laura Gómez Ganda

 .

Professionals

Joan Genesca Ferrer

 Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal m

Professionals

Miriam Mota

Soy técnica estadística en la Unidad de Estadística y Bioinformática (UEB) del Instituto de Investigación del Vall d'Hebron (VHIR)

Activities

1r Curso Angioedema basado en simulación para residentes de alergología

Professionals

Maria José Buzón Gómez

 I am a researcher with extensive training in virology and immunology and a strong interest in translational research. I am dedicated to the study of new therapies aimed at curing HIV, with special emphasis on the characterization, both in blood and in different tissues, of new cellular reservoirs of

News

The Multidisciplinary Committee on Pancreatic Cancer presents its research at the National Surgery Congress

 In three oral communications and a poster, professionals from the Services of Hepatobiliary and Pancreatic Surgery and Transplants and Medical Oncology of Vall d'Hebron explain new developments in the clinical approach to pancreatic cancer and acute pancreatitis.

News

Collaborative trial platforms position themselves as the best method to achieve a drug for non-alcoholic fatty liver disease

 One in four adults suffers from this hepatic disease for which there is still no specific pharmacological treatment.

News

Vall d'Hebron and BCN Peptides demonstrate the efficacy of a new drug to prevent metastasis

 The inhibition of integrin alpha9 (ITGA9) by the drug RA08 is a novel therapeutic strategy to prevent the dissemination of tumor cells.

Subscribe to our newsletters and be a part of Campus Life

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.